ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 195 filers reported holding ANI PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $621,939 | -26.6% | 10,712 | -31.9% | 0.01% | -28.6% |
Q2 2023 | $847,230 | +64.9% | 15,739 | +21.7% | 0.01% | +75.0% |
Q1 2023 | $513,858 | +97591.6% | 12,937 | -1.1% | 0.00% | 0.0% |
Q4 2022 | $526 | -99.9% | 13,076 | +18.9% | 0.00% | 0.0% |
Q3 2022 | $353,000 | -0.3% | 10,993 | -7.9% | 0.00% | 0.0% |
Q2 2022 | $354,000 | +14.9% | 11,941 | +8.9% | 0.00% | +33.3% |
Q1 2022 | $308,000 | -18.3% | 10,969 | +34.1% | 0.00% | -25.0% |
Q4 2021 | $377,000 | +56.4% | 8,180 | +11.3% | 0.00% | +33.3% |
Q3 2021 | $241,000 | -9.7% | 7,348 | -3.6% | 0.00% | 0.0% |
Q2 2021 | $267,000 | -0.4% | 7,619 | +2.6% | 0.00% | 0.0% |
Q1 2021 | $268,000 | +23.5% | 7,428 | -0.4% | 0.00% | 0.0% |
Q4 2020 | $217,000 | +3.3% | 7,461 | +0.2% | 0.00% | -25.0% |
Q3 2020 | $210,000 | -8.7% | 7,447 | +136.2% | 0.00% | 0.0% |
Q3 2019 | $230,000 | -3.0% | 3,153 | +9.3% | 0.00% | 0.0% |
Q2 2019 | $237,000 | +17.9% | 2,886 | +1.4% | 0.00% | +33.3% |
Q1 2019 | $201,000 | – | 2,847 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FIRST WILSHIRE SECURITIES MANAGEMENT INC | 327,929 | $9,218,000 | 3.24% |
Parkman Healthcare Partners LLC | 107,911 | $3,033,000 | 0.89% |
Global Alpha Capital Management Ltd. | 350,231 | $9,845,000 | 0.85% |
MARATHON CAPITAL MANAGEMENT | 75,010 | $2,109,000 | 0.60% |
TANG CAPITAL MANAGEMENT LLC | 100,000 | $2,811,000 | 0.56% |
EMERALD ADVISERS, LLC | 354,045 | $9,952,000 | 0.38% |
Sio Capital Management, LLC | 40,000 | $1,124,000 | 0.37% |
EMERALD MUTUAL FUND ADVISERS TRUST | 299,493 | $8,419,000 | 0.37% |
Stonepine Capital Management, LLC | 26,060 | $733,000 | 0.30% |
Mitsubishi UFJ Asset Management (UK) Ltd. | 23,000 | $646,530,000 | 0.29% |